Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

492.42
+1.950.40%
Post-market: 498.686.26+1.27%17:15 EDT
Volume:1.25M
Turnover:613.82M
Market Cap:126.59B
PE:-236.74
High:498.41
Open:488.27
Low:484.97
Close:490.47
Loading ...

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead. -- Barrons.com

Dow Jones
·
27 Mar

IHI Corporation Transfers Shares of Construction Subsidiary to Vertex

TIPRANKS
·
27 Mar

Vortex Energy Corp. Announces Share Consolidation Effective April 1, 2025

TIPRANKS
·
27 Mar

Vertex Commerce Study: Returnuary’s Growing Complexity Forces Retailers to Keep Pace

GlobeNewswire
·
26 Mar

Microsoft Takes On Alphabet With This AI Advance. It's Copilot vs Gemini. -- Barrons.com

Dow Jones
·
26 Mar

Explorers Podcast: Vertex ready to claim its gold Reward

Stockheads
·
26 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
25 Mar

Vertex Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
25 Mar

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $512 From $500, Keeps Overweight Rating

MT Newswires Live
·
24 Mar

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy

Reuters
·
24 Mar

Press Release: Vertex Resource Group Ltd. Reports Fourth Quarter and Year End 2024 Results

Dow Jones
·
24 Mar

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks
·
22 Mar

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
22 Mar

Vortex Energy Proposes Share Consolidation to Streamline Structure

TIPRANKS
·
21 Mar

Vertex Price Target Maintained With a $61.00/Share by Citizens Capital Markets

Dow Jones
·
20 Mar

Vertex Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
20 Mar

Vertex’s Ambitious Growth Targets and Uncertain Near-Term Prospects: A Hold Rating Analysis

TIPRANKS
·
20 Mar

Vertex Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
20 Mar

Vertex’s Strategic Positioning and Growth Potential: A Buy Recommendation by Chris Quintero

TIPRANKS
·
20 Mar

Vertex Highlights Growth Strategies at Investor Day

TIPRANKS
·
20 Mar